| 1 |
33706313 | MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment. | 2022 |
1 |
| 2 |
34864772 | Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years). | 2022 Jan-Feb 01 |
1 |
| 3 |
34967003 | Prolactin signaling modulates stress-induced behavioral responses in a preclinical mouse model of migraine. | 2022 Jan |
1 |
| 4 |
33358454 | [Prolactinoma causing erectile dysfunction]. | 2021 Oct-Dec |
1 |
| 5 |
33902531 | Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study. | 2021 Apr 26 |
1 |
| 6 |
33914699 | Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature. | 2021 May 24 |
1 |
| 7 |
33961352 | Factors associated with the level of prolactin in patients under remission from Alcohol Use Disorder: A gender perspective. | 2021 Sep |
1 |
| 8 |
34106485 | Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. | 2021 Sep |
2 |
| 9 |
34173929 | Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients. | 2021 Dec |
1 |
| 10 |
34261980 | Treatment of hyperprolactinemia: A single-institute experience. | 2021 Nov 1 |
1 |
| 11 |
34446277 | Hyperprolactinemia after menopause: Diagnosis and management. | 2021 Sep |
1 |
| 12 |
34540295 | Prolactin-Secreting Leiomyoma Causing Hyperprolactinaemia Unresponsive to Dopamine Agonist Therapy and Resolution following Myomectomy. | 2021 |
1 |
| 13 |
31686376 | Prolactinomas and menopause: any changes in management? | 2020 Feb |
1 |
| 14 |
31802331 | Prolactinomas in males: any differences? | 2020 Feb |
1 |
| 15 |
31853893 | A middle cerebral artery ischemic stroke occurring in a child with a large prolactinoma. | 2020 Apr |
1 |
| 16 |
32243999 | Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management. | 2020 Jul 13 |
1 |
| 17 |
32392109 | Melatonin Modulates Lactation by Regulating Prolactin Secretion Via Tuberoinfundibular Dopaminergic Neurons in the Hypothalamus- Pituitary System. | 2020 |
1 |
| 18 |
32413670 | Methyldopa as an inductor of postpartum depression and maternal blues: A review. | 2020 Jul |
1 |
| 19 |
32429916 | Predictors of dopamine agonist resistance in prolactinoma patients. | 2020 May 19 |
1 |
| 20 |
32508315 | Dopamine agonists and antipsychotics. | 2020 Sep |
5 |
| 21 |
32597492 | Immunohistochemical detection of prolactin in clinically non-functioning pituitary adenomas. | 2020 |
2 |
| 22 |
32654174 | Sexual function and depressive symptoms in young women with hypoprolactinaemia. | 2020 Oct |
1 |
| 23 |
32737582 | Thyrotropin-releasing hormone axonal varicosities appear to innervate dopaminergic neurons in the human hypothalamus. | 2020 Sep |
2 |
| 24 |
32741482 | The Role of Dopamine Agonists in Pituitary Adenomas. | 2020 Sep |
1 |
| 25 |
32760348 | Malignant Prolactinoma With Liver Metastases Masquerading as Metastatic Gastrointestinal Stromal Tumor: A Case Report and Literature Review. | 2020 |
3 |
| 26 |
32781144 | Sellar Cholesterol Granuloma Mimicking Cystic Sellar Lesions: A Report of Three Cases and Literature Review. | 2020 Dec |
1 |
| 27 |
32793702 | Artesunate exerts anti-prolactinoma activity by inhibiting mitochondrial metabolism and inducing apoptosis. | 2020 Jul |
1 |
| 28 |
32857272 | Ectopic hyperprolactinaemia due to a malignant uterine tumor resembling ovarian sex cord tumors (UTROCST). | 2020 Dec |
2 |
| 29 |
33072650 | Schizophrenia and Macroprolactinoma: Is There a Deep Link? | 2020 |
1 |
| 30 |
33234470 | Retrospective analysis of 19 patients with 6-Pyruvoyl Tetrahydropterin Synthase Deficiency: Prolactin levels inversely correlate with growth. | 2020 Dec |
1 |
| 31 |
33254515 | Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus? | 2020 Nov |
2 |
| 32 |
33305662 | Dopamine agonists as genital endometriosis target therapy. | 2020 |
1 |
| 33 |
29940665 | Giant Prolactinomas: Outcomes of Multimodal Treatments for 42 Cases with Long-Term Follow-Up. | 2019 May |
1 |
| 34 |
30347396 | Hyperprolactinemia/Prolactinomas in the Postmenopausal Period: Challenges in Diagnosis and Management. | 2019 |
1 |
| 35 |
30660191 | Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report. | 2019 Jan 20 |
1 |
| 36 |
30828702 | A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How? | 2019 |
1 |
| 37 |
30852578 | Dopamine Agonists: From the 1970s to Today. | 2019 |
2 |
| 38 |
30967134 | A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. | 2019 Apr 9 |
2 |
| 39 |
30986806 | Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor. | 2019 Jun |
1 |
| 40 |
31106995 | Prolactin Elevations and Permeability Glycoprotein. | 2019 May 16 |
1 |
| 41 |
31167164 | Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors. | 2019 Aug |
1 |
| 42 |
31208951 | Clinical characterization of tremor in patients with phenylketonuria. | 2019 Sep - Oct |
1 |
| 43 |
31211288 | A Novel Patient Case Report to Show the Successful Termination of Untreatable Androgen-independent Prostate Cancer: Treatment with Cabergoline (Dopamine agonist). | 2019 |
2 |
| 44 |
31319705 | Evaluation of screening for drug use using postmortem prolactin levels in serum and cerebrospinal fluid. | 2019 Nov |
3 |
| 45 |
31328184 | The Suppression of Prolactin is required for the Treatment of Advanced Prostate Cancer. | 2019 |
1 |
| 46 |
31523679 | Ingestion of caffeine links dopamine and 5-hydroxytryptamine release during half immersion in 42°C hot water in a humans. | 2019 Aug |
1 |
| 47 |
32082942 | Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain-Part II. | 2019 Nov 1 |
3 |
| 48 |
32145165 | [Indicators of protein, lipid, carbohydrate, purine metabolism and the level of pituitary hormones in healthy men of 22-55 years old.] | 2019 |
3 |
| 49 |
28925774 | Resolution of dopamine agonist-resistant hyperprolactinemia by hysterectomy: a case report. | 2018 Mar |
1 |
| 50 |
28954263 | Beneficial Effects of High Doses of Cabergoline in the Treatment of Giant Prolactinoma Resistant to Dopamine Agonists: A Case Report with a 21-Year Follow-Up. | 2018 |
1 |